PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34905649-8 2022 Mechanistically, GDF11 significantly activates mammalian target of rapamycin complex 1 (mTORC1) and subsequently represses transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy. Sirolimus 67-76 transcription factor EB Homo sapiens 123-146 35020443-2 2022 The nuclear localization of TFEB is blocked by the mechanistic target of rapamycin complex 1 (mTORC1)-dependent phosphorylation of TFEB at multiple sites including Ser-211. Sirolimus 73-82 transcription factor EB Homo sapiens 28-32 35020443-2 2022 The nuclear localization of TFEB is blocked by the mechanistic target of rapamycin complex 1 (mTORC1)-dependent phosphorylation of TFEB at multiple sites including Ser-211. Sirolimus 73-82 transcription factor EB Homo sapiens 131-135 30546014-2 2018 TFEB activity is inhibited following its phosphorylation by mammalian target of rapamycin complex 1 (mTORC1) on the surface of the lysosome. Sirolimus 80-89 transcription factor EB Homo sapiens 0-4 33163944-4 2020 Here, we show that under pharmacological and genetic c-Abl inhibition, TFEB translocates into the nucleus promoting the expression of its target genes independently of its well-known regulator, mammalian target of rapamycin complex 1. Sirolimus 214-223 transcription factor EB Homo sapiens 71-75 26377470-5 2015 Treatment with rapamycin was found to independently restore PGC1alpha-TFEB signaling in a manner not requiring parkin activity and to abrogate impairment of mitochondrial quality control and neurodegenerative features associated with this in vivo model. Sirolimus 15-24 transcription factor EB Homo sapiens 70-74 27153139-9 2016 The use of Rapamycin (TORC1 inhibitor) was able on one hand to increase TFEB activation and, on the other hand, to reduce lipofuscin mass, potentiating the lysosomal functionality. Sirolimus 11-20 transcription factor EB Homo sapiens 72-76 27112200-7 2016 The activation of autophagy including TFEB is likely due to fisetin-mediated mammalian target of rapamycin complex 1 (mTORC1) inhibition, since the phosphorylation levels of p70S6 kinase and 4E-BP1 were decreased in the presence of fisetin. Sirolimus 97-106 transcription factor EB Homo sapiens 38-42 26377470-12 2015 Treatment with rapamycin independently restores PGC1alpha-TFEB signaling in a manner not requiring parkin activity and abrogates subsequent mitochondrial impairment and neuronal cell loss. Sirolimus 15-24 transcription factor EB Homo sapiens 58-62